| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |